Who owns Vikaly?
Vikaly is owned by Virbac (France, EPA: VIRP).[1]
This ownership is reported in official statements but has not yet been matched to a regulatory filing.
Evidence: Virbac — Annual Report 2025, Virbac SA, 27 April 2026. Last checked .
Key facts
- Current owner
- Virbac SA reported
- Owner HQ
- 🇫🇷 France, Carros
- Origin
- 🇫🇷 France
- Founded
- 2025
- Category
- Healthcare & pharma › Devices & animal health › Animal health
- Parent ticker
- EPA: VIRP
- Last verified
- · 2 sources
About Vikaly
Vikaly is a prescription cat food from Virbac that combines a clinical kidney diet with benazepril, an ACE inhibitor that reduces protein loss in the urine, so the medicine is eaten with each meal instead of being given as a tablet. Virbac calls it the world's first 2-in-1 medicated food for cats. It is for adult and senior cats with chronic kidney disease and proteinuria from IRIS stage 2, is sold in 1.5 kg bags, and was one of Virbac's major European launches of 2025.
Ownership timeline of Vikaly
Where Vikaly sits in Virbac
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Virbac ownership tree →
See the full Virbac brand portfolio (5) →
Other brands owned by Virbac
Virbac controls 5 brands on Brandtree, 3 of them in healthcare & pharma.
Also in healthcare & pharma
Founded in the 2020s
- Zenifel (2025)
Other brands in animal health, and who owns them
The 16 brands in animal health on Brandtree belong to 4 owners. The largest is Neogen, with 5; Virbac has 3.
| Brand | Owner | Owner based in |
|---|---|---|
| IDEXX Catalyst One | IDEXX | 🇺🇸 United States |
| BotVax B | Neogen | 🇺🇸 United States |
| Daxocox | Animalcare | 🇬🇧 United Kingdom |
| IDEXX inVue Dx | IDEXX | 🇺🇸 United States |
| IDEXX ProCyte One | IDEXX | 🇺🇸 United States |
| IDEXX SediVue Dx | IDEXX | 🇺🇸 United States |
| IDEXX SNAP | IDEXX | 🇺🇸 United States |
| Ideal | Neogen | 🇺🇸 United States |
About the owner: Virbac
Virbac is a publicly listed company headquartered in Carros, France, founded in 1968. Brandtree records 5 brands under its control, and it is listed as EPA: VIRP.
Virbac SA is a French animal-health company, established in 1968 in Carros by the veterinarian Pierre-Richard Dick, that makes and sells medicines, vaccines, health products and pet food for companion and farm animals. Its shares are listed in compartment A of Euronext Paris, and at the end of 2025 the Dick family group held 50.09% of the capital and 66.21% of the voting rights. Revenue in 2025 was €1,465 million, 869 million of it from companion animals. It has about 6,400 employees, sales subsidiaries in 36 countries and production sites in 12, and it bought Japan's Sasaeah group in April 2024, Türkiye's Mopsan in December 2024 and the rights to Thyronorm in December 2025.
🇫🇷 Vikaly and other French brands
Brandtree records a controlling owner for 325 brands that began in France. 100 of them (31%) are now controlled by a company headquartered in another country; Vikaly is not one of them.
Frequently asked questions
Who is the parent company of Vikaly?
The parent company of Vikaly is Virbac, a publicly listed company headquartered in France.
Is Vikaly French?
Yes. Vikaly originated in France in 2025 and its owner, Virbac, is also headquartered in France.
Is Vikaly still owned by Virbac?
Yes. As of 23 October 2026, Vikaly is still owned by Virbac. The ownership record was last checked against primary sources on that date.
Sources (2) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Virbac — Annual Report 2025 — Virbac SA, Annual report, published 27 April 2026; retrieved 23 October 2026.
- [2] Virbac Launches Vikaly™: The World’s First 2-in-1 Medicated Food for Cats — Virbac Ltd, Official press release, published 7 November 2025; retrieved 23 October 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.